James Osborne, DO
Facial Plastic Surgery · Phoenix, AZNPI 1912944042
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.0% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $821, 2.1 times the $383 reported in 2019.
Across 122 payments — averaging $20.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$494
- GSK$424
- Regeneron Healthcare Solutions, Inc.$391
- Optinose US, Inc.$387
- Stryker$358
- Aerin Medical Inc.$153
- plus $352 from 8 others
What the payments were for
- Consulting fees$803%
- Food & beverage$2,43295%
- Education$492%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 25 | $494 |
| GSK | 22 | $424 |
| Regeneron Healthcare Solutions, Inc. | 15 | $391 |
| Optinose US, Inc. | 17 | $387 |
| Stryker | 12 | $358 |
| Aerin Medical Inc. | 7 | $153 |
| Neurent Medical Limited | 10 | $108 |
| Intersect ENT, Inc. | 4 | $60 |
| Baxter Healthcare | 1 | $48 |
| Smith+Nephew | 3 | $47 |
| Novartis | 3 | $43 |
| Phadia US Inc. | 1 | $16 |
| Amgen | 1 | $16 |
| Alk-abello, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few facial plastic surgery providers in Arizonato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 24 | $96,288 |
| Ipratropium Bromide | 70 | $2,388 |
| Mupirocin | 78 | $784 |
| Famotidine | 59 | $638 |
| Azelastine Hcl | 25 | $619 |
| Ofloxacin | 28 | $462 |
| Montelukast Sodium | 28 | $439 |
| Cephalexin | 69 | $389 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $278 |
| Prednisone | 112 | $277 |
| Clindamycin Hcl | 29 | $275 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 50 | $254 |
| Fluticasone Propionate | 17 | $241 |
| Lorazepam | 38 | $40 |
Paid to pharmacies, not to this prescriber.
Other facial plastic surgery in Phoenix
- Brian RizzoPhoenix$47K
- Samuel DevictorPhoenix$2K
- Veena VatsGilbert$9K
- Niki PatelTucson$6K
- Jonathan WiggenhornGoodyear$3K
- Jerold OlsonTucson$2K
- Tamarah FratianniFlagstaff$961
- Kelly BomerScottsdale$633
- Robert WoodsScottsdale$436
- Paul HoldenScottsdale$319
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.